Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Parkinson's Disease at a moderate stage (Hoehn & Yahr stage 1.5 to 3)
- People who are able to temporarily pause their Parkinson's medications in the morning without experiencing significant problems
- People who are able to give informed consent, and who have sufficient mental clarity to do so (a short memory and thinking test score of 18 or above may be used to confirm this if there is any doubt)
- People who are between 50 and 80 years old (a small number of exceptions outside this age range may be considered)
- People who are willing to complete a 3-day food diary on one occasion, which helps the trial team place participants into one of two groups: those who experience increased cravings for sweet foods, and those who do not
Who may not be able to join:
- People who have another significant neurological condition that primarily affects the brain or central nervous system (for example, multiple sclerosis)
- People who have been diagnosed with diabetes or pre-diabetes
- People who take medications that affect how the body processes blood sugar — this includes a wide range of medicines such as diabetes drugs, steroids (glucocorticoids), certain immunosuppressants, beta-blockers, certain water tablets, certain asthma medications, some antipsychotics, some antidepressants, some epilepsy medications, cholesterol-lowering drugs (statins), HIV medications, lithium, and others (confirm with trial site for the full list)
- People who have a cardiac pacemaker or a brain stimulation device (brain pacemaker)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 004943150023983
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of Insulin in µU/mL; Motor function; Concentration of Blood Glucose in mg/dL
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.